SlideShare ist ein Scribd-Unternehmen logo
1 von 3
Downloaden Sie, um offline zu lesen
review article
                                                                                                                            Diabetes, Obesity and Metabolism 13: 204–206, 2011.
                                                                                                                                                © 2011 Blackwell Publishing Ltd
article
review




          Dietary prescriptions for the overweight patient:
          the potential benefits of low-carbohydrate diets
          in insulin resistance
          M. W. Lee1 & K. Fujioka2
          1 Diabetes/Endocrinology, Scripps Clinic, San Diego, CA, USA
          2 Diabetes/Endocrinology, Scripps Clinical Research Center, La Jolla, CA, USA




          Obesity in the USA continues to be a medical problem of epidemic proportions, affecting one-third of American adults. This increase in
          body weight and body mass index (BMI) is a risk factor for insulin resistance; individuals with insulin resistance are at increased risk for the
          development of type 2 diabetes and cardiovascular disease. The identification of effective dietary treatments (e.g. low-carbohydrate diet,
          low-fat diet) for patient populations with insulin resistance remains controversial. While a variety of dietary approaches will result in weight
          and cardiac risk factor reduction, individuals who have been identified as insulin-resistant may derive additional short-term weight loss results
          from a low-carbohydrate diet compared to a low-fat diet.
          Keywords: dietary intervention, insulin resistance, obesity therapy

          Date submitted 30 July 2010; date of first decision 8 September 2010; date of final acceptance 8 October 2010




          Introduction                                                                                 Risk factors for insulin resistance include obesity, sedentary
                                                                                                   lifestyle, non-Caucasian ethnicity, history of gestational
          Obesity in the USA continues to be a medical problem
                                                                                                   diabetes or glucose intolerance and a family history of type
          of epidemic proportions, affecting one-third of American
                                                                                                   2 diabetes, hypertension or cardiovascular disease (Table 1). In
          adults [1]. Considerable controversy remains regarding the
                                                                                                   addition, an individual is at increased risk for insulin resistance
          identification of effective dietary treatments. Low-carbohydrate
                                                                                                   if there is already a personal diagnosis of cardiovascular disease,
          diets have been shown to have at least comparable safety and
                                                                                                   hypertension, polycystic ovarian syndrome, nonalcoholic fatty
          efficacy as diets with higher carbohydrate content [2,3]. It is
                                                                                                   liver disease or acanthosis nigricans [4].
          possible, however, that low-carbohydrate diets are particularly
                                                                                                       While insulin resistance can be measured via the
          appropriate for patient populations with insulin resistance. In
                                                                                                   hyperinsulinemic–euglycaemic clamp technique and the
          addition to reviewing the studies that support and contradict
                                                                                                   frequently sampled intravenous glucose tolerance test, these
          this theory, this article will discuss the concept of insulin
                                                                                                   procedures may not be suitable or convenient for most
          resistance, its medical consequences and means of identifying
                                                                                                   medical practitioners. The homeostasis model assessment of
          those with this condition.
                                                                                                   insulin resistance (HOMA-IR) can also be used, but requires
                                                                                                   the measurement of fasting insulin and glucose values. A
          Insulin Resistance                                                                       predictive model for insulin resistance based only on clinical
                                                                                                   measurements (without laboratory studies) has been proposed,
          Secreted by the beta cells of the pancreas, insulin is responsible                       in which an individual is predicted to be insulin resistant if
          for the proper metabolism of glucose and fatty acids by liver,                           (i) BMI is greater than 28.7 kg/m2 , or (ii) BMI is greater than
          muscle and adipose tissue. Insulin resistance, with its compen-                          27.0 kg/m2 with a family history of diabetes. This model carried
          satory hyperinsulinemia, is associated with glucose intolerance,                         a sensitivity of 78.7% and a specificity of 79.6% [5]. Such a
          abnormal uric acid metabolism, dyslipidemia, hypertension,                               predictive model may be useful for the busy primary care
          inflammation and endothelial dysfunction (figure 1). Individu-                             provider during the assessment of the overweight patient.
          als with insulin resistance and compensatory hyperinsulinemia
          are thus at increased risk for the development of type 2 diabetes
          and cardiovascular disease [4].                                                          Low-Carbohydrate Diets in Insulin
                                                                                                   Resistance
          Correspondence to: Dr Michael W. Lee, Diabetes/Endocrinology, Scripps Clinic, 12395 El
          Camino Real, Ste 317, San Diego 92130, CA, USA.                                          It has been postulated that individual differences in insulin
          E-mail: milee@scrippsclinic.com                                                          secretion may affect a particular diet’s ability to induce weight
DIABETES, OBESITY AND METABOLISM                                                                         review article

                                                                       Glucose
                                                                     Intolerance

                                                                                               Abnormal
                                    Endothelial                                                 Uric Acid
                                    Dysfunction                                                Metabolism




                                                                       Insulin
                                                                     Resistance
                           Inflammation                                                              Dyslipidemia




                                                    Prothrombotic                  Hemodynamic
                                                       Factors                       Changes




Figure 1. Disease-related consequences of insulin resistance [4].

Table 1. Risk factors for insulin resistance [4].                           weight on the high-carbohydrate/low-fat diet than the low-
                                                                            carbohydrate/high-fat diet (13.5 vs. 6.8%) [7].
Overweight/obesity
                                                                               A similar 24-week pilot study showed comparable results.
Sedentary lifestyle                                                         Thirty-two overweight adults had insulin values measured
Non-Caucasian ethnicity                                                     30 min after a 75-g oral glucose tolerance test, and were assigned
Family history of type 2 diabetes, hypertension or cardiovascular disease   to either a high-glycaemic load diet or a low-glycaemic load
History of gestational diabetes or glucose intolerance                      diet. The composition of the high-glycaemic load diet was
History of cardiovascular disease, hypertension, polycystic ovarian
                                                                            60% carbohydrate, 20% protein, 20% fat, 15 g fibre/1000 kcal,
  syndrome, nonalcoholic fatty liver disease or acanthosis nigricans
                                                                            mean estimated daily glycaemic index of 86 and a glycaemic
                                                                            load of 116 g/1000 kcal. The composition of the low-glycaemic
                                                                            load diet was 40% carbohydrate, 30% protein, 30% fat, 15 g
loss. In individuals with a high insulin response to glucose, a             fibre/1000 kcal, mean estimated daily glycaemic index of 53
high-glycaemic load results in increased postprandial insulin
                                                                            and a glycaemic load of 45 g/1000 kcal. Subjects with high
levels, favouring fatty acid uptake, inhibition of lipolysis and
                                                                            insulin secretion lost more weight on a low-glycaemic load
energy storage. High-glycaemic-load diets also result in a lower
                                                                            diet compared to a high-glycaemic load diet (p = 0.047).
glucose nadir and increases in counterregulatory hormones,
which may cause hunger and overeating [6].                                  In addition, low-glycaemic load subjects with high insulin
   In a 16-week clinical study, 12 insulin-sensitive and 9                  secretion lost more weight than low-glycaemic load subjects
insulin-resistant obese women were randomized to either                     with low insulin secretion (p = 0.027) [8].
a high-carbohydrate/low-fat (60% carbohydrates and 20%                         In an 18-month clinical trial, 73 obese young adults were
fat) diet or a low-carbohydrate/high-fat (40% carbohydrates                 randomized to either a low-glycaemic load (40% carbohydrates
and 40% fat) diet. Insulin-resistant women lost 13.4% of                    and 35% fat) diet or a low-fat (55% carbohydrate and 20% fat)
their initial body weight on the low-carbohydrate/high-fat                  diet. Serum insulin concentrations at 30 min after a 75-g dose of
plan, compared to 8.5% on the high-carbohydrate/low-fat                     oral glucose were measured at baseline. For those subjects with
plan. Interestingly, insulin-sensitive women lost more                      high insulin secretion, the low-glycaemic load diet resulted in



Volume 13 No. 3 March 2011                                                                        doi:10.1111/j.1463-1326.2010.01328.x 205
review article                                                                            DIABETES, OBESITY AND METABOLISM


greater weight loss (5.8 vs. 1.2 kg, p = 0.004) than the low-fat     in both normal and hypertriglyceridemic subjects [15,16].
diet [9].                                                            It is therefore reasonable for health care practitioners to
   Most recently, 45 obese insulin-resistant female subjects were    recommend that individuals with insulin resistance avoid low-
randomized to either a low-fat (60% carbohydrate, 20% fat and        fat/high-carbohydrate diets, unless there is concurrent weight
20% protein) diet or a low-carbohydrate (45% carbohydrate,           loss [4].
35% fat and 20% protein) diet. Both dietary interventions
utilized prepared calorie-controlled meals. After 12 weeks,
the low-fat group lost 7.34 kg, compared to 9.33 kg in the
                                                                     Conflict of Interest
low-carbohydrate group (p = 0.04) [10].                              Dr Lee and Dr Fujioka designed the study, did data collection
   In contrast, 31 obese women underwent insulin resistance          and analysis. Dr Lee wrote the manuscript. Both the authors
testing (somatostatin/insulin/glucose infusion, as well as           have no competing interests.
postprandial insulin measurements) and were placed on a
hypocaloric (1000 kcal deficit) diet composed primarily of
                                                                     References
liquid nutritional supplements. There was no correlation
between insulin resistance and the amount of weight loss              1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in
                                                                         obesity among US adults. JAMA 2010; 303: 235–241.
at 2 months for the 20 subjects who successfully lost weight.
The ten insulin-resistant subjects lost 9.3 ± 0.5 kg, while the       2. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison
                                                                         of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and
ten insulin-sensitive subjects lost 9.1 ± 0.3 kg. As for the
                                                                         heart disease risk reduction: a randomized trial. JAMA 2005; 293: 43–53.
11 subjects who were unsuccessful in losing weight, six were
                                                                      3. Nordmann AJ, Nordmann A, Briel M et al. Effects of low-carbohydrate vs
insulin-sensitive and five were insulin-resistant [11].
                                                                         low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis
   A longer study by the same investigators utilized a                   of randomized controlled trials. Arch Intern Med 2006; 166: 285–293.
standard (500 kcal deficit) hypocaloric diet and the weight
                                                                      4. Einorn D, Reaven GM, Cobin RH et al. ACE position statement on the insulin
loss medication sibutramine, and found similar results.                  resistance syndrome. Endocr Pract 2003; 9: 240–252.
Among 24 obese women provided a dietician-prescribed
                                                                      5. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP.
plan and sibutramine 15 mg/day over 4 months, there was                  Identification of individuals with insulin resistance using routine clinical
no difference in weight loss between the insulin-resistant               measurements. Diabetes 2005; 54: 333–339.
and insulin-sensitive groups. The 13 insulin-resistant subjects
                                                                      6. Ludwig DS. The glycemic index: physiological mechanisms relating
lost 8.6 ± 1.3 kg, while the 11 insulin-sensitive subjects               to obesity, diabetes, and cardiovascular disease. JAMA 2002; 287:
lost 7.9 ± 1.4 kg. The insulin suppression test, utilizing               2414–2423.
somatostatin/insulin/glucose infusions, was again used to             7. Cornier MA, Donahoo WT, Pereira R et al. Insulin sensitivity determines
determine insulin sensitivity and insulin resistance [12].               the effectiveness of dietary macronutrient composition on weight loss in
   Finally, a landmark 2-year trial examined the effects of diets        obese women. Obes Res 2005; 13: 703–709.
with a variety of macronutrient compositions, and found no            8. Pittas AG, Das SK, Hajduk CL et al. A low-glycemic load diet facilitates
difference in weight loss. Eight hundred and eleven overweight           greater weight loss in overweight adults with high insulin secretion but
and obese adults were randomized to one of four diets; fat               not in overweight adults with low insulin secretion in the CALERIE trial.
content ranged between 20 and 40%, protein content ranged                Diabetes Care 2005; 28: 2939–2941.
between 15 and 25%, and carbohydrate content ranged between           9. Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS. Effects of
35 and 65%. Group and individual sessions were used to provide           a low-glycemic load vs low-fat diet in obese young adults. JAMA 2007;
750 kcal deficit meal plans. Weight loss was similar among all            297: 2092–2102.
four diets (3–4 kg), and there was no difference between the         10. Plodkowski RA, St Jeor ST, Nguyen QT, Fernandez GCJ, Dahir VB. Effect of
highest carbohydrate diet and the lowest carbohydrate diet.              diet composition on weight loss in insulin resistant people. Endocr Rev
                                                                         2010; 31: S31.
While no formal testing for insulin resistance was performed
in the study subjects, the presence of metabolic syndrome            11. McLaughlin T, Abbasi F, Carantoni M, Schaaf P, Reaven G. Differences in
                                                                         insulin resistance do not predict weight loss in hypocaloric diets in healthy
decreased in all four groups after 2 years, from 32% to
                                                                         obese women. J Clin Endocrinol Metab 1999; 84: 578–581.
approximately 20% [13].
                                                                     12. McLaughlin T, Abbasi F, Kim HS, Lamendola C, Schaaf P, Reaven G.
                                                                         Relationship between insulin resistance, weight loss, and coronary heart
                                                                         disease risk in healthy, obese women. Metabolism 2001; 50: 795–800.
Recommendations
                                                                     13. Sacks FM, Bray GA, Carey VJ et al. Comparison of weight-loss diets with
The prevailing consensus is that a variety of dietary approaches         different compositions of fat, protein, and carbohydrates. NEJM 2009; 360:
will result in weight and cardiac risk factor reduction, with            859–873.
greater adherence producing greater results [2,13,14]. How-          14. Rock CL, Pakiz B, Flatt SW, Quintana EL. Randomized trial of a multifaceted
ever, individuals who have been identified as insulin-resistant           commercial weight loss program. Obesity 2007; 15: 939–949.
may derive additional short-term weight loss results from a          15. Coulston AM, Liu GC, Reaven GM. Plasma glucose, insulin and lipid
low-carbohydrate diet compared to a low-fat diet. A low-                 responses to high-carbohydrate low-fat diets in normal humans.
carbohydrate approach in such patients would also be less                Metabolism 1983; 32: 52–56.
likely to exacerbate the existing hyperinsulinemic state, as stud-   16. Liu GC, Coulston AM, Reaven GM. Effect of high-carbohydrate low-fat diets
ies have showed that a high-carbohydrate (60% of calories) diet          on plasma glucose, insulin and lipid responses in hypertriglyceridemic
adversely affected postprandial insulin and triglyceride levels          humans. Metabolism 1983; 32: 750–753.




206 Lee and Fujioka                                                                                             Volume 13 No. 3 March 2011

Weitere ähnliche Inhalte

Was ist angesagt?

2010 exenatide and weight loss
2010 exenatide and weight loss2010 exenatide and weight loss
2010 exenatide and weight lossAgrin Life
 
Feasting or fasting in ICU? by Professor Marianne Chapman
Feasting or fasting in ICU? by Professor Marianne ChapmanFeasting or fasting in ICU? by Professor Marianne Chapman
Feasting or fasting in ICU? by Professor Marianne ChapmanSMACC Conference
 
The Benefit of Fasting in Neurological Disorders
The Benefit of Fasting in Neurological DisordersThe Benefit of Fasting in Neurological Disorders
The Benefit of Fasting in Neurological DisordersAdeWijaya21
 
S13054 018-2015-z
S13054 018-2015-zS13054 018-2015-z
S13054 018-2015-zAdiel Ojeda
 
Gliadin, Intestinal Permeability, and Celiac Disease: From Innate Immunity to...
Gliadin, Intestinal Permeability, and Celiac Disease: From Innate Immunity to...Gliadin, Intestinal Permeability, and Celiac Disease: From Innate Immunity to...
Gliadin, Intestinal Permeability, and Celiac Disease: From Innate Immunity to...Letizia Saturni
 
Malnutrition in the hospital
Malnutrition in the hospitalMalnutrition in the hospital
Malnutrition in the hospitalCorrie T
 
WCPD 2012:Jaakko Tuomilehto
WCPD 2012:Jaakko TuomilehtoWCPD 2012:Jaakko Tuomilehto
WCPD 2012:Jaakko TuomilehtoCoffee_Health
 
Common digestive concerns
Common digestive concernsCommon digestive concerns
Common digestive concernsEllen Wong
 
Role of probiotics in ICU pro and cons
Role of probiotics in ICU pro and consRole of probiotics in ICU pro and cons
Role of probiotics in ICU pro and consmansoor masjedi
 
I M Abstract Summary Of Med Pub
I M  Abstract  Summary Of  Med  PubI M  Abstract  Summary Of  Med  Pub
I M Abstract Summary Of Med PubAvis Betancourt
 
Diagnostico y clasificasion diabetes 2013
Diagnostico y clasificasion diabetes 2013Diagnostico y clasificasion diabetes 2013
Diagnostico y clasificasion diabetes 2013Juana Reynoso R.
 
gene therapy of diabetes mellitus
 gene therapy of diabetes mellitus gene therapy of diabetes mellitus
gene therapy of diabetes mellitusSanju Kaladharan
 

Was ist angesagt? (20)

Espen uci 2019
Espen uci 2019Espen uci 2019
Espen uci 2019
 
Cardio disease may2009
Cardio disease may2009Cardio disease may2009
Cardio disease may2009
 
2010 exenatide and weight loss
2010 exenatide and weight loss2010 exenatide and weight loss
2010 exenatide and weight loss
 
Feasting or fasting in ICU? by Professor Marianne Chapman
Feasting or fasting in ICU? by Professor Marianne ChapmanFeasting or fasting in ICU? by Professor Marianne Chapman
Feasting or fasting in ICU? by Professor Marianne Chapman
 
Wischmeyer2017
Wischmeyer2017Wischmeyer2017
Wischmeyer2017
 
The Benefit of Fasting in Neurological Disorders
The Benefit of Fasting in Neurological DisordersThe Benefit of Fasting in Neurological Disorders
The Benefit of Fasting in Neurological Disorders
 
S13054 018-2015-z
S13054 018-2015-zS13054 018-2015-z
S13054 018-2015-z
 
Diabetes Care: Part One
Diabetes Care: Part OneDiabetes Care: Part One
Diabetes Care: Part One
 
Nutirion Training Module By Mili
Nutirion Training Module By Mili Nutirion Training Module By Mili
Nutirion Training Module By Mili
 
Gliadin, Intestinal Permeability, and Celiac Disease: From Innate Immunity to...
Gliadin, Intestinal Permeability, and Celiac Disease: From Innate Immunity to...Gliadin, Intestinal Permeability, and Celiac Disease: From Innate Immunity to...
Gliadin, Intestinal Permeability, and Celiac Disease: From Innate Immunity to...
 
Diabetes
DiabetesDiabetes
Diabetes
 
NYU Langone Medical Center
NYU Langone Medical CenterNYU Langone Medical Center
NYU Langone Medical Center
 
Malnutrition in the hospital
Malnutrition in the hospitalMalnutrition in the hospital
Malnutrition in the hospital
 
WCPD 2012:Jaakko Tuomilehto
WCPD 2012:Jaakko TuomilehtoWCPD 2012:Jaakko Tuomilehto
WCPD 2012:Jaakko Tuomilehto
 
Common digestive concerns
Common digestive concernsCommon digestive concerns
Common digestive concerns
 
Role of probiotics in ICU pro and cons
Role of probiotics in ICU pro and consRole of probiotics in ICU pro and cons
Role of probiotics in ICU pro and cons
 
I M Abstract Summary Of Med Pub
I M  Abstract  Summary Of  Med  PubI M  Abstract  Summary Of  Med  Pub
I M Abstract Summary Of Med Pub
 
Sitagliptin
SitagliptinSitagliptin
Sitagliptin
 
Diagnostico y clasificasion diabetes 2013
Diagnostico y clasificasion diabetes 2013Diagnostico y clasificasion diabetes 2013
Diagnostico y clasificasion diabetes 2013
 
gene therapy of diabetes mellitus
 gene therapy of diabetes mellitus gene therapy of diabetes mellitus
gene therapy of diabetes mellitus
 

Ähnlich wie Dieta hiperproteica para obeso com resistência à insulina

Hiperuricemia diabetes y sindrome metabolico2
Hiperuricemia diabetes y sindrome metabolico2Hiperuricemia diabetes y sindrome metabolico2
Hiperuricemia diabetes y sindrome metabolico2Residentes1hun
 
Case study - DM 2, CKD 4
Case study - DM 2, CKD 4Case study - DM 2, CKD 4
Case study - DM 2, CKD 4Reynel Dan
 
Fasting and Caloric Restriction Show Promise for Reducing Type 2 Diabetes Bio...
Fasting and Caloric Restriction Show Promise for Reducing Type 2 Diabetes Bio...Fasting and Caloric Restriction Show Promise for Reducing Type 2 Diabetes Bio...
Fasting and Caloric Restriction Show Promise for Reducing Type 2 Diabetes Bio...Premier Publishers
 
El sindrome metabolico
El sindrome metabolicoEl sindrome metabolico
El sindrome metabolicoDeiber Pinzon
 
Metabolic syndrome & its complications
Metabolic syndrome & its complicationsMetabolic syndrome & its complications
Metabolic syndrome & its complicationsPradeep Singh Narwat
 
Role of dietary habits in reduction of insulin
Role of dietary habits in reduction of insulinRole of dietary habits in reduction of insulin
Role of dietary habits in reduction of insulinfardina_omi
 
Idf course module 2 overview of diabetes management
Idf course module 2 overview of diabetes managementIdf course module 2 overview of diabetes management
Idf course module 2 overview of diabetes managementDiabetes for all
 
The obesity epidemic: a hidden addiction?
The obesity epidemic: a hidden addiction?The obesity epidemic: a hidden addiction?
The obesity epidemic: a hidden addiction?Simon Thornley
 
Mechanisms of Glucose Homeostasis Final
Mechanisms of Glucose Homeostasis FinalMechanisms of Glucose Homeostasis Final
Mechanisms of Glucose Homeostasis FinalDan Svedberg
 
Bio 100
Bio 100Bio 100
Bio 100sal327
 
Ada diganosis and clasification dm .full
Ada diganosis and clasification dm .fullAda diganosis and clasification dm .full
Ada diganosis and clasification dm .fullyepez1987
 
session 27 DIABETES M .ppt
session 27 DIABETES M .pptsession 27 DIABETES M .ppt
session 27 DIABETES M .pptAugustusCaesar7
 
A Case Study On A 52-Year-Old Female Patient Diagnosed With Type II Diabetes ...
A Case Study On A 52-Year-Old Female Patient Diagnosed With Type II Diabetes ...A Case Study On A 52-Year-Old Female Patient Diagnosed With Type II Diabetes ...
A Case Study On A 52-Year-Old Female Patient Diagnosed With Type II Diabetes ...Richard Hogue
 
Celiac Case study
Celiac Case studyCeliac Case study
Celiac Case studyYeyan Jin
 

Ähnlich wie Dieta hiperproteica para obeso com resistência à insulina (20)

Hiperuricemia diabetes y sindrome metabolico2
Hiperuricemia diabetes y sindrome metabolico2Hiperuricemia diabetes y sindrome metabolico2
Hiperuricemia diabetes y sindrome metabolico2
 
Diabetes
DiabetesDiabetes
Diabetes
 
Case study - DM 2, CKD 4
Case study - DM 2, CKD 4Case study - DM 2, CKD 4
Case study - DM 2, CKD 4
 
Fasting and Caloric Restriction Show Promise for Reducing Type 2 Diabetes Bio...
Fasting and Caloric Restriction Show Promise for Reducing Type 2 Diabetes Bio...Fasting and Caloric Restriction Show Promise for Reducing Type 2 Diabetes Bio...
Fasting and Caloric Restriction Show Promise for Reducing Type 2 Diabetes Bio...
 
El sindrome metabolico
El sindrome metabolicoEl sindrome metabolico
El sindrome metabolico
 
Nutrition in icu
Nutrition in icuNutrition in icu
Nutrition in icu
 
Diabetes Mellitus PPT
Diabetes Mellitus PPTDiabetes Mellitus PPT
Diabetes Mellitus PPT
 
Metabolic syndrome & its complications
Metabolic syndrome & its complicationsMetabolic syndrome & its complications
Metabolic syndrome & its complications
 
Role of dietary habits in reduction of insulin
Role of dietary habits in reduction of insulinRole of dietary habits in reduction of insulin
Role of dietary habits in reduction of insulin
 
Idf course module 2 overview of diabetes management
Idf course module 2 overview of diabetes managementIdf course module 2 overview of diabetes management
Idf course module 2 overview of diabetes management
 
The obesity epidemic: a hidden addiction?
The obesity epidemic: a hidden addiction?The obesity epidemic: a hidden addiction?
The obesity epidemic: a hidden addiction?
 
A3 Final Draft
A3 Final DraftA3 Final Draft
A3 Final Draft
 
Mechanisms of Glucose Homeostasis Final
Mechanisms of Glucose Homeostasis FinalMechanisms of Glucose Homeostasis Final
Mechanisms of Glucose Homeostasis Final
 
Bio 100
Bio 100Bio 100
Bio 100
 
Ada diganosis and clasification dm .full
Ada diganosis and clasification dm .fullAda diganosis and clasification dm .full
Ada diganosis and clasification dm .full
 
Different forms of diabetes
Different forms of diabetesDifferent forms of diabetes
Different forms of diabetes
 
session 27 DIABETES M .ppt
session 27 DIABETES M .pptsession 27 DIABETES M .ppt
session 27 DIABETES M .ppt
 
A Case Study On A 52-Year-Old Female Patient Diagnosed With Type II Diabetes ...
A Case Study On A 52-Year-Old Female Patient Diagnosed With Type II Diabetes ...A Case Study On A 52-Year-Old Female Patient Diagnosed With Type II Diabetes ...
A Case Study On A 52-Year-Old Female Patient Diagnosed With Type II Diabetes ...
 
Celiac Case study
Celiac Case studyCeliac Case study
Celiac Case study
 
Diabetes
DiabetesDiabetes
Diabetes
 

Mehr von Ruy Pantoja

Brown adipose tissue
Brown adipose tissueBrown adipose tissue
Brown adipose tissueRuy Pantoja
 
Não somos quentes o suficiente ?
Não somos quentes o suficiente ?Não somos quentes o suficiente ?
Não somos quentes o suficiente ?Ruy Pantoja
 
MACROPHAGE AND BROWN FAT
MACROPHAGE AND BROWN FATMACROPHAGE AND BROWN FAT
MACROPHAGE AND BROWN FATRuy Pantoja
 
Proteinas 14 3-3 e insulina
Proteinas 14 3-3 e insulinaProteinas 14 3-3 e insulina
Proteinas 14 3-3 e insulinaRuy Pantoja
 
Beta cell stress en dm2 b
Beta cell stress en dm2 bBeta cell stress en dm2 b
Beta cell stress en dm2 bRuy Pantoja
 
Beta cell stres in dm2 a
Beta cell stres in dm2 aBeta cell stres in dm2 a
Beta cell stres in dm2 aRuy Pantoja
 
Beta cell failure, stress and dm2
Beta cell failure, stress and dm2Beta cell failure, stress and dm2
Beta cell failure, stress and dm2Ruy Pantoja
 
Dpp4 e angiogênese
Dpp4 e angiogêneseDpp4 e angiogênese
Dpp4 e angiogêneseRuy Pantoja
 
DIABETES AND CANCER
DIABETES AND CANCERDIABETES AND CANCER
DIABETES AND CANCERRuy Pantoja
 
Glicemia e fat food ingestion
Glicemia e fat food ingestionGlicemia e fat food ingestion
Glicemia e fat food ingestionRuy Pantoja
 
Sitagliptina e proteção em ca diferenciado da tireóide.x
Sitagliptina e proteção em ca diferenciado da tireóide.xSitagliptina e proteção em ca diferenciado da tireóide.x
Sitagliptina e proteção em ca diferenciado da tireóide.xRuy Pantoja
 
Exetimibe melhora dm diminuindo nafld.x
Exetimibe melhora dm diminuindo nafld.xExetimibe melhora dm diminuindo nafld.x
Exetimibe melhora dm diminuindo nafld.xRuy Pantoja
 
Dpp4 i for the treatment of ACNE
Dpp4 i for the treatment of ACNEDpp4 i for the treatment of ACNE
Dpp4 i for the treatment of ACNERuy Pantoja
 
GLP 1 E GIP: DIFERENÇAS E SEMELHANÇAS
GLP 1 E GIP: DIFERENÇAS E SEMELHANÇASGLP 1 E GIP: DIFERENÇAS E SEMELHANÇAS
GLP 1 E GIP: DIFERENÇAS E SEMELHANÇASRuy Pantoja
 
To my colleagues from many parts of the world
To my colleagues from many parts of the worldTo my colleagues from many parts of the world
To my colleagues from many parts of the worldRuy Pantoja
 
FENTERMIN DOENSNT INCREASE HYPERTENSION
FENTERMIN DOENSNT INCREASE HYPERTENSIONFENTERMIN DOENSNT INCREASE HYPERTENSION
FENTERMIN DOENSNT INCREASE HYPERTENSIONRuy Pantoja
 
Doença cardiovascular
Doença cardiovascularDoença cardiovascular
Doença cardiovascularRuy Pantoja
 
Cancer cell metabolism
Cancer cell metabolismCancer cell metabolism
Cancer cell metabolismRuy Pantoja
 
Dpp4 beta cell preservation
Dpp4 beta cell preservationDpp4 beta cell preservation
Dpp4 beta cell preservationRuy Pantoja
 

Mehr von Ruy Pantoja (20)

Drug discovery
Drug discoveryDrug discovery
Drug discovery
 
Brown adipose tissue
Brown adipose tissueBrown adipose tissue
Brown adipose tissue
 
Não somos quentes o suficiente ?
Não somos quentes o suficiente ?Não somos quentes o suficiente ?
Não somos quentes o suficiente ?
 
MACROPHAGE AND BROWN FAT
MACROPHAGE AND BROWN FATMACROPHAGE AND BROWN FAT
MACROPHAGE AND BROWN FAT
 
Proteinas 14 3-3 e insulina
Proteinas 14 3-3 e insulinaProteinas 14 3-3 e insulina
Proteinas 14 3-3 e insulina
 
Beta cell stress en dm2 b
Beta cell stress en dm2 bBeta cell stress en dm2 b
Beta cell stress en dm2 b
 
Beta cell stres in dm2 a
Beta cell stres in dm2 aBeta cell stres in dm2 a
Beta cell stres in dm2 a
 
Beta cell failure, stress and dm2
Beta cell failure, stress and dm2Beta cell failure, stress and dm2
Beta cell failure, stress and dm2
 
Dpp4 e angiogênese
Dpp4 e angiogêneseDpp4 e angiogênese
Dpp4 e angiogênese
 
DIABETES AND CANCER
DIABETES AND CANCERDIABETES AND CANCER
DIABETES AND CANCER
 
Glicemia e fat food ingestion
Glicemia e fat food ingestionGlicemia e fat food ingestion
Glicemia e fat food ingestion
 
Sitagliptina e proteção em ca diferenciado da tireóide.x
Sitagliptina e proteção em ca diferenciado da tireóide.xSitagliptina e proteção em ca diferenciado da tireóide.x
Sitagliptina e proteção em ca diferenciado da tireóide.x
 
Exetimibe melhora dm diminuindo nafld.x
Exetimibe melhora dm diminuindo nafld.xExetimibe melhora dm diminuindo nafld.x
Exetimibe melhora dm diminuindo nafld.x
 
Dpp4 i for the treatment of ACNE
Dpp4 i for the treatment of ACNEDpp4 i for the treatment of ACNE
Dpp4 i for the treatment of ACNE
 
GLP 1 E GIP: DIFERENÇAS E SEMELHANÇAS
GLP 1 E GIP: DIFERENÇAS E SEMELHANÇASGLP 1 E GIP: DIFERENÇAS E SEMELHANÇAS
GLP 1 E GIP: DIFERENÇAS E SEMELHANÇAS
 
To my colleagues from many parts of the world
To my colleagues from many parts of the worldTo my colleagues from many parts of the world
To my colleagues from many parts of the world
 
FENTERMIN DOENSNT INCREASE HYPERTENSION
FENTERMIN DOENSNT INCREASE HYPERTENSIONFENTERMIN DOENSNT INCREASE HYPERTENSION
FENTERMIN DOENSNT INCREASE HYPERTENSION
 
Doença cardiovascular
Doença cardiovascularDoença cardiovascular
Doença cardiovascular
 
Cancer cell metabolism
Cancer cell metabolismCancer cell metabolism
Cancer cell metabolism
 
Dpp4 beta cell preservation
Dpp4 beta cell preservationDpp4 beta cell preservation
Dpp4 beta cell preservation
 

Kürzlich hochgeladen

Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 

Kürzlich hochgeladen (20)

Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 

Dieta hiperproteica para obeso com resistência à insulina

  • 1. review article Diabetes, Obesity and Metabolism 13: 204–206, 2011. © 2011 Blackwell Publishing Ltd article review Dietary prescriptions for the overweight patient: the potential benefits of low-carbohydrate diets in insulin resistance M. W. Lee1 & K. Fujioka2 1 Diabetes/Endocrinology, Scripps Clinic, San Diego, CA, USA 2 Diabetes/Endocrinology, Scripps Clinical Research Center, La Jolla, CA, USA Obesity in the USA continues to be a medical problem of epidemic proportions, affecting one-third of American adults. This increase in body weight and body mass index (BMI) is a risk factor for insulin resistance; individuals with insulin resistance are at increased risk for the development of type 2 diabetes and cardiovascular disease. The identification of effective dietary treatments (e.g. low-carbohydrate diet, low-fat diet) for patient populations with insulin resistance remains controversial. While a variety of dietary approaches will result in weight and cardiac risk factor reduction, individuals who have been identified as insulin-resistant may derive additional short-term weight loss results from a low-carbohydrate diet compared to a low-fat diet. Keywords: dietary intervention, insulin resistance, obesity therapy Date submitted 30 July 2010; date of first decision 8 September 2010; date of final acceptance 8 October 2010 Introduction Risk factors for insulin resistance include obesity, sedentary lifestyle, non-Caucasian ethnicity, history of gestational Obesity in the USA continues to be a medical problem diabetes or glucose intolerance and a family history of type of epidemic proportions, affecting one-third of American 2 diabetes, hypertension or cardiovascular disease (Table 1). In adults [1]. Considerable controversy remains regarding the addition, an individual is at increased risk for insulin resistance identification of effective dietary treatments. Low-carbohydrate if there is already a personal diagnosis of cardiovascular disease, diets have been shown to have at least comparable safety and hypertension, polycystic ovarian syndrome, nonalcoholic fatty efficacy as diets with higher carbohydrate content [2,3]. It is liver disease or acanthosis nigricans [4]. possible, however, that low-carbohydrate diets are particularly While insulin resistance can be measured via the appropriate for patient populations with insulin resistance. In hyperinsulinemic–euglycaemic clamp technique and the addition to reviewing the studies that support and contradict frequently sampled intravenous glucose tolerance test, these this theory, this article will discuss the concept of insulin procedures may not be suitable or convenient for most resistance, its medical consequences and means of identifying medical practitioners. The homeostasis model assessment of those with this condition. insulin resistance (HOMA-IR) can also be used, but requires the measurement of fasting insulin and glucose values. A Insulin Resistance predictive model for insulin resistance based only on clinical measurements (without laboratory studies) has been proposed, Secreted by the beta cells of the pancreas, insulin is responsible in which an individual is predicted to be insulin resistant if for the proper metabolism of glucose and fatty acids by liver, (i) BMI is greater than 28.7 kg/m2 , or (ii) BMI is greater than muscle and adipose tissue. Insulin resistance, with its compen- 27.0 kg/m2 with a family history of diabetes. This model carried satory hyperinsulinemia, is associated with glucose intolerance, a sensitivity of 78.7% and a specificity of 79.6% [5]. Such a abnormal uric acid metabolism, dyslipidemia, hypertension, predictive model may be useful for the busy primary care inflammation and endothelial dysfunction (figure 1). Individu- provider during the assessment of the overweight patient. als with insulin resistance and compensatory hyperinsulinemia are thus at increased risk for the development of type 2 diabetes and cardiovascular disease [4]. Low-Carbohydrate Diets in Insulin Resistance Correspondence to: Dr Michael W. Lee, Diabetes/Endocrinology, Scripps Clinic, 12395 El Camino Real, Ste 317, San Diego 92130, CA, USA. It has been postulated that individual differences in insulin E-mail: milee@scrippsclinic.com secretion may affect a particular diet’s ability to induce weight
  • 2. DIABETES, OBESITY AND METABOLISM review article Glucose Intolerance Abnormal Endothelial Uric Acid Dysfunction Metabolism Insulin Resistance Inflammation Dyslipidemia Prothrombotic Hemodynamic Factors Changes Figure 1. Disease-related consequences of insulin resistance [4]. Table 1. Risk factors for insulin resistance [4]. weight on the high-carbohydrate/low-fat diet than the low- carbohydrate/high-fat diet (13.5 vs. 6.8%) [7]. Overweight/obesity A similar 24-week pilot study showed comparable results. Sedentary lifestyle Thirty-two overweight adults had insulin values measured Non-Caucasian ethnicity 30 min after a 75-g oral glucose tolerance test, and were assigned Family history of type 2 diabetes, hypertension or cardiovascular disease to either a high-glycaemic load diet or a low-glycaemic load History of gestational diabetes or glucose intolerance diet. The composition of the high-glycaemic load diet was History of cardiovascular disease, hypertension, polycystic ovarian 60% carbohydrate, 20% protein, 20% fat, 15 g fibre/1000 kcal, syndrome, nonalcoholic fatty liver disease or acanthosis nigricans mean estimated daily glycaemic index of 86 and a glycaemic load of 116 g/1000 kcal. The composition of the low-glycaemic load diet was 40% carbohydrate, 30% protein, 30% fat, 15 g loss. In individuals with a high insulin response to glucose, a fibre/1000 kcal, mean estimated daily glycaemic index of 53 high-glycaemic load results in increased postprandial insulin and a glycaemic load of 45 g/1000 kcal. Subjects with high levels, favouring fatty acid uptake, inhibition of lipolysis and insulin secretion lost more weight on a low-glycaemic load energy storage. High-glycaemic-load diets also result in a lower diet compared to a high-glycaemic load diet (p = 0.047). glucose nadir and increases in counterregulatory hormones, which may cause hunger and overeating [6]. In addition, low-glycaemic load subjects with high insulin In a 16-week clinical study, 12 insulin-sensitive and 9 secretion lost more weight than low-glycaemic load subjects insulin-resistant obese women were randomized to either with low insulin secretion (p = 0.027) [8]. a high-carbohydrate/low-fat (60% carbohydrates and 20% In an 18-month clinical trial, 73 obese young adults were fat) diet or a low-carbohydrate/high-fat (40% carbohydrates randomized to either a low-glycaemic load (40% carbohydrates and 40% fat) diet. Insulin-resistant women lost 13.4% of and 35% fat) diet or a low-fat (55% carbohydrate and 20% fat) their initial body weight on the low-carbohydrate/high-fat diet. Serum insulin concentrations at 30 min after a 75-g dose of plan, compared to 8.5% on the high-carbohydrate/low-fat oral glucose were measured at baseline. For those subjects with plan. Interestingly, insulin-sensitive women lost more high insulin secretion, the low-glycaemic load diet resulted in Volume 13 No. 3 March 2011 doi:10.1111/j.1463-1326.2010.01328.x 205
  • 3. review article DIABETES, OBESITY AND METABOLISM greater weight loss (5.8 vs. 1.2 kg, p = 0.004) than the low-fat in both normal and hypertriglyceridemic subjects [15,16]. diet [9]. It is therefore reasonable for health care practitioners to Most recently, 45 obese insulin-resistant female subjects were recommend that individuals with insulin resistance avoid low- randomized to either a low-fat (60% carbohydrate, 20% fat and fat/high-carbohydrate diets, unless there is concurrent weight 20% protein) diet or a low-carbohydrate (45% carbohydrate, loss [4]. 35% fat and 20% protein) diet. Both dietary interventions utilized prepared calorie-controlled meals. After 12 weeks, the low-fat group lost 7.34 kg, compared to 9.33 kg in the Conflict of Interest low-carbohydrate group (p = 0.04) [10]. Dr Lee and Dr Fujioka designed the study, did data collection In contrast, 31 obese women underwent insulin resistance and analysis. Dr Lee wrote the manuscript. Both the authors testing (somatostatin/insulin/glucose infusion, as well as have no competing interests. postprandial insulin measurements) and were placed on a hypocaloric (1000 kcal deficit) diet composed primarily of References liquid nutritional supplements. There was no correlation between insulin resistance and the amount of weight loss 1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults. JAMA 2010; 303: 235–241. at 2 months for the 20 subjects who successfully lost weight. The ten insulin-resistant subjects lost 9.3 ± 0.5 kg, while the 2. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and ten insulin-sensitive subjects lost 9.1 ± 0.3 kg. As for the heart disease risk reduction: a randomized trial. JAMA 2005; 293: 43–53. 11 subjects who were unsuccessful in losing weight, six were 3. Nordmann AJ, Nordmann A, Briel M et al. Effects of low-carbohydrate vs insulin-sensitive and five were insulin-resistant [11]. low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis A longer study by the same investigators utilized a of randomized controlled trials. Arch Intern Med 2006; 166: 285–293. standard (500 kcal deficit) hypocaloric diet and the weight 4. Einorn D, Reaven GM, Cobin RH et al. ACE position statement on the insulin loss medication sibutramine, and found similar results. resistance syndrome. Endocr Pract 2003; 9: 240–252. Among 24 obese women provided a dietician-prescribed 5. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. plan and sibutramine 15 mg/day over 4 months, there was Identification of individuals with insulin resistance using routine clinical no difference in weight loss between the insulin-resistant measurements. Diabetes 2005; 54: 333–339. and insulin-sensitive groups. The 13 insulin-resistant subjects 6. Ludwig DS. The glycemic index: physiological mechanisms relating lost 8.6 ± 1.3 kg, while the 11 insulin-sensitive subjects to obesity, diabetes, and cardiovascular disease. JAMA 2002; 287: lost 7.9 ± 1.4 kg. The insulin suppression test, utilizing 2414–2423. somatostatin/insulin/glucose infusions, was again used to 7. Cornier MA, Donahoo WT, Pereira R et al. Insulin sensitivity determines determine insulin sensitivity and insulin resistance [12]. the effectiveness of dietary macronutrient composition on weight loss in Finally, a landmark 2-year trial examined the effects of diets obese women. Obes Res 2005; 13: 703–709. with a variety of macronutrient compositions, and found no 8. Pittas AG, Das SK, Hajduk CL et al. A low-glycemic load diet facilitates difference in weight loss. Eight hundred and eleven overweight greater weight loss in overweight adults with high insulin secretion but and obese adults were randomized to one of four diets; fat not in overweight adults with low insulin secretion in the CALERIE trial. content ranged between 20 and 40%, protein content ranged Diabetes Care 2005; 28: 2939–2941. between 15 and 25%, and carbohydrate content ranged between 9. Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS. Effects of 35 and 65%. Group and individual sessions were used to provide a low-glycemic load vs low-fat diet in obese young adults. JAMA 2007; 750 kcal deficit meal plans. Weight loss was similar among all 297: 2092–2102. four diets (3–4 kg), and there was no difference between the 10. Plodkowski RA, St Jeor ST, Nguyen QT, Fernandez GCJ, Dahir VB. Effect of highest carbohydrate diet and the lowest carbohydrate diet. diet composition on weight loss in insulin resistant people. Endocr Rev 2010; 31: S31. While no formal testing for insulin resistance was performed in the study subjects, the presence of metabolic syndrome 11. McLaughlin T, Abbasi F, Carantoni M, Schaaf P, Reaven G. Differences in insulin resistance do not predict weight loss in hypocaloric diets in healthy decreased in all four groups after 2 years, from 32% to obese women. J Clin Endocrinol Metab 1999; 84: 578–581. approximately 20% [13]. 12. McLaughlin T, Abbasi F, Kim HS, Lamendola C, Schaaf P, Reaven G. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 2001; 50: 795–800. Recommendations 13. Sacks FM, Bray GA, Carey VJ et al. Comparison of weight-loss diets with The prevailing consensus is that a variety of dietary approaches different compositions of fat, protein, and carbohydrates. NEJM 2009; 360: will result in weight and cardiac risk factor reduction, with 859–873. greater adherence producing greater results [2,13,14]. How- 14. Rock CL, Pakiz B, Flatt SW, Quintana EL. Randomized trial of a multifaceted ever, individuals who have been identified as insulin-resistant commercial weight loss program. Obesity 2007; 15: 939–949. may derive additional short-term weight loss results from a 15. Coulston AM, Liu GC, Reaven GM. Plasma glucose, insulin and lipid low-carbohydrate diet compared to a low-fat diet. A low- responses to high-carbohydrate low-fat diets in normal humans. carbohydrate approach in such patients would also be less Metabolism 1983; 32: 52–56. likely to exacerbate the existing hyperinsulinemic state, as stud- 16. Liu GC, Coulston AM, Reaven GM. Effect of high-carbohydrate low-fat diets ies have showed that a high-carbohydrate (60% of calories) diet on plasma glucose, insulin and lipid responses in hypertriglyceridemic adversely affected postprandial insulin and triglyceride levels humans. Metabolism 1983; 32: 750–753. 206 Lee and Fujioka Volume 13 No. 3 March 2011